The Applied Health competition, announced in May 2003, was Genome Canada's first targeted approach to funding large-scale genomics and proteomics research. Specifically, the successful projects were focused on the development and application of genomics and proteomics tools to improve the prediction, prevention and treatment of human disease. The application process was similar to Competition I with the additional requirement of a plan for a potential therapy or diagnostic tool to be ready for testing in a clinical setting within five years of the project's start date.

Projects co-funded and managed by Genome BC through this competition include:

• Genomic Tools for Diagnosis and Evaluation of Mental Retardation
• Innovative Genomic Applications to Develop Clinical Biomarkers and Novel Therapies for Common Iron Metabolism Disorders
• Genotype-specific Approaches to Therapy in Childhood (GATC)
• Development and Validation of Comparative Genomic Hybridization Microarrays for Clinical Use in Cancer
• Application of Pharmacogenomics for Rational Chemotherapy of Lung Cancer
• Better Biomarkers of Acute and Chronic Allograft Rejection

Click here to see all projects funded in this competition across Canada.